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Background: DNA methylation plays an important role in regulating gene expression during many biological
processes. However, the mechanism of DNA-methylation-dependent gene regulation is not fully understood. Here,
we explore two possible DNA methylation regulatory mechanisms with opposite modes of gene expression regulation.
Results: By comparing the genome-wide methylation and expression patterns in different tissues, we find that majority
of tissue-specific differentially methylated regions (T-DMRs) are negatively correlated with expression of their associated
genes (negative T-DMRs), consistent with the classical dogma that DNA methylation suppresses gene expression;
however, a significant portion of T-DMRs are positively correlated with gene expression (positive T-DMRs). We
observe that the positive T-DMRs have similar genomic location as negative T-DMRs, except that the positive T-DMRs
are more enriched in the promoter regions. Both positive and negative T-DMRs are enriched in DNase I hypersensitivity
sites (DHSs), suggesting that both are likely to be functional. The CpG sites of both positive and negative T-DMRs are also
more evolutionarily conserved than the genomic background. Interestingly, the putative target genes of the positive
T-DMR are enriched for negative regulators such as transcriptional repressors, suggesting a novel mode of indirect
DNA methylation inhibition of expression through transcriptional repressors. Likewise, two distinct sets of DNA
sequence motifs exist for positive and negative T-DMRs, suggesting that two distinct sets of transcription factors
(TFs) are involved in positive and negative regulation mediated by DNA methylation.
Conclusions: We find both negative and positive association between T-DMRs and gene expression, which implies the
existence of two different mechanisms of DNA methylation-dependent gene regulation.
Keywords: DNA methylation, Tissue-specific, Differentially methylated region, Gene regulationBackground
DNA methylation regulates many biological processes,
including development and disease by modulation of
gene expression. Early studies on DNA methylation
focused on CpG islands, DNA segments with a high
density of CpG sites. Among the important findings
about CpG islands are: (1) CpG islands tend to co-
localize with the transcription start sites (TSS) of genes
[1,2]; (2) promoter CpG islands are usually unmethy-
lated (CpG island methylation is strongly associated* Correspondence: smerbs@jhmi.edu; jiang.qian@jhmi.edu
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unless otherwise stated.with reduced gene expression) [1,2]; and 3) treatment of
methylated CpG islands with methytransferase
inhibitors generally increases gene expression [3]. CpG
island methylation is also important for tissue-specific
gene regulation. For example, certain tissue-specific
genes are methylated in the tissues in which they are not
expressed, but not in tissues where they are expressed
[4,5]. However, the situation is more complex than a
simple “on-off” model since the promoter CpG islands of
some genes remain unmethylated even in cell types that
do not express the gene [6].
It is generally accepted that DNA methylation represses
gene expression. Recent technical advances, especially a
variety of deep sequencing-based techniques, have madeis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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genome-wide scale [7-9]. Unbiased analysis of genome-
wide methylation patterns reveals that DNA methylation
is not always negatively correlated with gene expression.
In fact, the methylation of a significant fraction of DNA
methylation sites are positively correlated with gene ex-
pression [10], challenging the traditional view that DNA
methylation represses gene expression. For the methyla-
tion sites that are positively correlated with gene expres-
sion, many questions remain to be answered. For example,
are these methylation sites functional? Do they preferen-
tially regulate downstream genes with certain gene func-
tions? Do they interact with different TFs?
To address these questions, we utilized datasets of
genome-wide tissue-specific DNA methylation and gene
expression to perform a detailed survey of potential regu-
latory roles of tissue-specific differentially methylated sites
(T-DMRs). The genome-wide methylation profiles were
obtained by the improved comprehensive high-throughput
array for relative methylation (CHARM) array [11], which
has no bias to promoter and CpG islands and requires
only small amount of tissue samples. We find that the
T-DMRs that are positively correlated with gene expres-
sion are likely to be functional and that the genes associ-
ated with these T-DMRs are enriched for those that
negatively regulate transcription and metabolism, sug-
gesting a novel, two-layer mechanism of DNA methylation-
dependent gene regulation. Furthermore, motif analysis
reveals that distinct sets of TFs are likely to be involved in
either positive or negative regulation mediated by DNA
methylation. Huge difference in sequence composition
between the two sets of motifs implies different regula-
tory mechanisms for DNA methylation-mediated gene
regulation.
Results
A significant number of T-DMRs positively correlate with
gene expression
In our previous genome-wide profiling of DNA methy-
lation profiles of mouse retina and brain [11], we identi-
fied 2498 T-DMRs. To explore the potential regulatory
role of these T-DMRs, we integrated the methylation
dataset with a genome-wide gene expression dataset ob-
tained from the same tissues [12]. We compared the
two tissues and calculated the difference in gene expres-
sion (ΔE) and the difference of DNA methylation (ΔM)
of a T-DMR within a gene region (proximal T-DMR)
from 4 kb upstream of the TSS to the end of transcrip-
tion. We did not limit our interest to gene promoters
since it has been shown that gene-body DNA methyla-
tion also plays a role in tissue-specific gene regulation
[13]. In total, 952 unique proximal T-DMRs are associ-
ated with genes whose expression showed at least 25%
fold change between the two tissues. The majority ofthe proximal T-DMRs (66%, red dots in Figure 1a) are
negatively correlated with gene expression (negative T-
DMRs), e.g. ΔM of the T-DMR and ΔE of the correspond-
ing gene are in opposite directions. Methylation of the
remaining 34% of T-DMRs (blue dots in Figure 1a) is posi-
tively correlated with gene expression (positive T-DMRs).
This proportion is clearly different from a random simula-
tion by shuffling actual ΔM and ΔE (49% and 51% for
negative and positive T-DMRs, respectively).
In addition to the proximal T-DMRs, we also investi-
gated distal T-DMRs located beyond 4 kb upstream of the
TSS. To assign the potential target genes of these distal T-
DMRs, we used the predicted enhancer-promoter relation-
ships [14]. 297 unique distal T-DMRs (407 T-DMR-gene
pairs) overlap enhancers, 49% of which are negative T-
DMRs and 51% are positively T-DMRs (Figure 1b).
Figure 1c and d show one example of an upstream T-
DMR positively that correlated with downstream gene
expression. Spalt-Like Transcription Factor 1 (Sall1) is a
transcriptional repressor that plays a critical role in cor-
tical neurogenesis [15,16]. We identified a T-DMR at
about 3 kb upstream of TSS, where the methylation level
of brain was higher than that of retina. In the expression
microarray analysis, Sall1 had a higher expression level
(linear 2-fold change) in brain than in retina.Negative and positive T-DMRs are potentially functional
To evaluate whether T-DMRs, especially the positive T-
DMRs, might play a role in gene regulation, we analysed a
series of genomic features of the positive T-DMRs and
compared them with those of negative T-DMRs. In general,
positive and negative T-DMRs have similar distributions at
all genomic locations (Figure 2). Interestingly, 15% of posi-
tive T-DMRs are located upstream, compared to 10% of
negative T-DMRs (p = 5.9 × 10−16, binominal model).
Next, we compared the position of T-DMRs with known
functional elements. Specifically, we examined the overlap
of the T-DMRs and DNase I hypersensitivity sites (DHSs),
short regions of open chromatin indicative of active tran-
scription. Of the DHS regions observed in adult mouse
retina and/or brain [17-19], 65% are present exclusively in
retina or brain (tissue-specific DHSs) (Figure 3a). The
remaining 35% are present in both tissues (shared DHSs).
Interestingly, about 18% of T-DMRs are within DHSs,
which is a significant overrepresentation compared with
random expectation (13%, p = 3.2 × 10−69, Figure 3b),
consistent with other reports [20]. More importantly, a
large majority (83%) of T-DMRs within DHSs are lo-
cated at tissue-specific DHSs. In contrast, only 17% of
the T-DMRs overlap shared DHSs, which is signifi-
cantly underrepresented compared to random expect-
ation (35%, p = 1.3 × 10−108). These results suggest that
T-DMRs are likely to play a role in tissue-specific gene
Figure 1 A significant portion of differentially methylated regions show positive correlation with gene expression (blue dots).
(a) Scatter plot of ΔE and ΔM of proximal T-DMRs and genes. (b) Scatter plot of ΔE and ΔM of distal T-DMRs and genes. One example (gene
Sall1) shows positive correlation between methylation difference within upstream T-DMR (c) and gene expression change (d). The error bars in
(d) represent the standard deviation of gene expression between triplicates of retina and duplicates of brain.
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positive and negative T-DMRs are located within DHSs
compared to that of all T-DMRs (Figure 3b, p = 2.5 × 10−5
and 1.0 × 10−4, respectively).
Sequences within T-DMRs are known to be more evolu-
tionary conserved than other genome regions [21]. Here
we examined the evolutionary conservation (PhastCons)
of the CpG sites within negative and positive T-DMRs,
and compared them to the CpG sites within the whole
genome and in all exons on the CHARM array.Figure 2 Positive T-DMRs have similar genome locations as
negative T-DMRs.Conservation scores of both negative and positive T-
DMRs are higher than that of genomic CpG sites, but
lower than those of CpG sites in exons only (Figure 4).
Moreover, positive T-DMRs have more conserved CpG
sites than negative T-DMRs.
In summary, our result suggests that positive T-DMRs
are likely to play a functional role in regulating tissue-
associated gene expression as indicated by several lines
of evidence, including genomic location, overlap with
functional elements and evolutionary conservation.
Multiple T-DMRs can be associated with one gene
For genes that may be controlled by multiple T-DMRs,
we divided T-DMR sets into coherent and incoherent,
based upon whether or not the multiple T-DMRs had
the same correlation direction with gene expression. For
example, a coherent set of four positive DMRs were
identified in the first intron of ventral anterior homeobox
2 (Vax2), which plays an important role in retinal devel-
opment [22]. The methylation level of these 4 T-DMRs
are all higher in retina than in brain (Figure 5a), and
gene expression of Vax2 is almost linear 2-fold greater
in retina than in brain (Figure 5b). In contrast, Kv chan-
nel interacting protein 3, calsenilin (Kcnip3) has an
Figure 3 T-DMRs are enriched in DHS regions. (a) Schematic plot for tissue-specific DHS and shared DHS; (b) Percentage of T-DMRs covered
by DHS.
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with one positive and one negative T-DMR. The gene ex-
pression data showed that Kcnip3 had a linear 4-fold
higher gene expression level in brain (Figure 5d).
Overall, 247 unique genes are associated with multiple
T-DMRs. Among them, 79 are associated with incoher-
ent T-DMR sets (e.g. Kcnip3). While keeping the same
ΔE for each gene, after randomly shuffling the T-DMRs
ΔM across the genes, we found that the expected num-
ber of genes associated with incoherent T-DMR sets was
145 (Figure 5e), suggesting that genes are less likely to
be regulated by incoherent T-DMR sets (Z = −9.38). Of
the 168 genes associated with coherent T-DMR sets, the
expression of 111 genes is negatively correlated with the
corresponding T-DMR set, which is much higher than
expected (44 genes, Z = 11.51). In contrast, the numberFigure 4 Both positive and negative T-DMRs are more conserved
than genomic background. Cumulative distribution is shown as the
percentage of CpG sites under the corresponding PhastCons score in
negative T-DMRs (red), positive T-DMRs (blue), all probes on the
CHARM array (black, as negative control), and exons (brown, as positive
control), respectively. The distribution describes the percentage of the
CpG sites that have a conservation score less than or equal to a given
conservation score (x-axis). Basically, the curves on the top are less
conserved than those on the bottom.of genes associated with coherent positive T-DMRs (e.g.
Vax2) is 57, the same as the expected distribution.
Transcription repressors are more likely to be regulated
by positive T-DMRs
We performed gene ontology (GO) analysis on genes as-
sociated with either negative (534 genes) or positive (330
genes) T-DMRs. Genes associated with incoherent T-
DMR sets were excluded for this analysis. It is not
surprising to see that genes associated with negative T-
DMRs are enriched for diverse types of biological func-
tions such as “visual perception/sensory perception of
light stimulus,” “neurological system process,” and “ion
transport” (Figure 6a), reflecting tissue-specific features.
Intriguingly, we found that genes associated with posi-
tive T-DMRs, e.g. Sall1 and Vax2 previously mentioned,
often encode negative regulators such as “negative regu-
lation of RNA metabolic process/nitrogen compound
metabolic process,” “negative regulation of gene expres-
sion/transcription/transcription” and “negative regula-
tion of biosynthetic process” (Figure 6b). In total, 74
genes out 330 genes (22%) whose expression was posi-
tively correlated with T-DMRs encoded negative regula-
tors (compared to 15% in background, p = 4.3 × 10−5).
To test whether our finding could be generalized to
other systems, we performed similar analysis on the data
from a human tissue-specific DNA methylation study
using brain and liver in an independent study published
by Irizarry et al. [10]. In this study, 1023 and 175 genes
were identified to be associated with a negative or posi-
tive T-DMR, respectively. Interestingly, the 175 genes as-
sociated with positive T-DMRs are also enriched for
negative regulators (gray bars in Figure 6b).
Our finding suggests a new mode of DNA methylation-
dependent regulation of tissue-specific expression: while
the majority of genes appear to be directly inhibited by
DNA methylation (Figure 6c), some genes may be indir-
ectly inhibited by DNA methylation that is associated with
expression of specific repressors (Figure 6d).
Figure 5 Genes possibly regulated by multiple T-DMRs. (a) 4 coherent T-DMRs found on Vax2; (b) Gene expression of Vax2; (c) 2 incoherent
T-DMRs found on Kcnip3; (d) Gene expression of Kcnip3; (e) Number of genes with incoherent, coherent negative, and coherent positive T-DMRs,
respectively. The error bars represent the standard deviation of randomly shuffling results for 10,000 times.
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and negative gene regulation
To further explore the molecular mechanisms that differ-
entiate possible positive and negative regulation via DNA
methylation, we predicted the transcription factor binding
sites that associate with the two types of T-DMRs. AllFigure 6 Genes encoding transcriptional repressors are more likely to
enriched in genes correlated with negative T-DMRs; (b) GO functions that
tissue data (blue) and human tissue data (gray); (c) and (d) Schematic plot
respectively. “R1” in (d) represents transcription repressors.possible 6-mers in the T-DMRs were enumerated and
compared to the occurrence of each motif in randomly se-
lected genomic regions. The significant motifs were identi-
fied based on p-values (see Methods).
We predicted 233 and 50 motifs that are specifically
associated with either negative or positive T-DMRs,be associated with positive T-DMRs. (a) GO functions that are
are enriched in genes correlated with positive T-DMRs for both mouse
s of a T-DMR negatively and positively regulating gene expression,
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both positive and negative T-DMRs, which we termed
“dual” motifs. The results suggest that positive and
negative regulations are largely governed by distinct TFs
(Figure 7a). If we focused on the T-DMRs that over-
lapped with DHSs only, 29, 42 and 6 motifs were
obtained for negative, positive and dual regulation, re-
spectively, (Figure 7b). Additional file 1: Table S1 lists all
significantly enriched motifs identified in Figure 7a and
b with corresponding p-values after FDR correction. The
motif analyses in all T-DMRs and those within only
DHS showed great consistency. First, 44 motifs were sig-
nificant in both analyses, while only 13 motifs were ex-
pected (Z = 9.5) (Figure 7c). Second, among these 44
motifs, 28 were predicted to have the same regulation
role (i.e. positive, negative and dual), while only 1 motif
was expected to share the same role (Z = 24.8) (Figure 7c
and d). Third, the enrichment score of all 6-mer occur-
ences in two analyses also showed significant correlation
(Additional file 2: Figure S1). The comparison suggested
that our motif analysis was robust and not sensitive to
the input set of T-DMRs.
Notably, those motifs that are associated with negative
or positive T-DMRs have different numbers of CpG sites
within the motif (Figure 7e). Only 14.2% of motifsFigure 7 Distinct sets of DNA motifs were found in positive and nega
(black) found in all T-DMRs regulating gene expression for FDR < 0.01. Gray
obtained in T-DMRs overlapped with DHSs for FDR < 0.05; (c) The numbers
regulation roles compared to expected numbers; (d) Heatmap of regulatio
motifs containing a CpG for each motif group in (a). Gray bar is percentagassociated with negative T-DMRs contain at least one
CpG site. Similarly, 9.3% of the motifs associated with
dual regulation contain a CpG site. Both of these were
significantly depleted (p = 9.4 × 10−9 and 2.0 × 10−5, re-
spectively), as 29.0% of all possible 6-mers contained a
CpG. In contrast, 78.0% of motifs associated with posi-
tive regulation contain a CpG site, which is significantly
enriched (p = 4.9 × 10−13). Our finding implies that the
methylation might occur in the nearby CpG sites for the
negative T-DMRs, while the methylation in the positive
T-DMRs is likely to occur directly on the TF binding
sites, suggesting again that there exist different regula-
tory mechanisms for positive and negative T-DMRs.
A recent study suggests that some TFs can recognize
both methylated and unmethylated motifs [23]. Among
the 358 motifs in the negative, positive and dual T-
DMRs, 79 of them contain at least one CpG. We com-
pared these 79 motifs to both known methylated and
unmethylated TF-binding consensus sequences. Motifs
were compared to unmethylated consensus sequences in
databases JASPAR [24,25] and UniPROBE [26] using
TOMTOM [27]. Additionally, motifs were compared to
motifs identified in our previous work that preferentially
bind to methylated DNA [23]. For each CpG-containing
DNA motif, we obtained two TFs, one that recognizestive T-DMRs. (a) 233 negative (red), 50 positive (blue), and 75 dual
dots are other non-significant 6-mers in the study; (b) Similar results
of significant motifs in both (a) and (b) and motifs playing the same
n role of significant motifs in both analyses; (e) Percentage of 6-mer
e of all 6-mer motifs with a CpG.
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methylated state. Figure 8 shows several examples for
which a consensus sequence is predicted to bind differ-
ent TFs based on the methylation state of the CpG
within the motif. For instance, the motif ACCGCA from
the T-DMR negative regulation group is similar to the
binding sequences of interferon regulatory factor 4 (Irf4).
However, the methylated form of the motif can be rec-
ognized by recombination signal binding protein for im-
munoglobulin kappa J region (RBPJ) (Figure 8).
Discussions and conclusions
CpG methylation has been thought to disrupt TF-DNA
interactions either directly [28], or indirectly by recruiting
sequence-independent methyl CpG binding domain pro-
teins that occupy the methylated promoters and compete
for the TF binding sites [29]. However, this traditional
view has been challenged by several recent studies. For
example, a mass spectrometry-based screen and a protein-
binding microarray approach were recently used to iden-
tify TFs that preferentially bind to methylated CpG sites
[23,30,31]. These results suggest that the mechanism of
DNA methylation mediated gene regulation is more com-
plicated than a purely inhibitory role.
In this study, we characterized T-DMRs and correlated
them with the expression levels of associated genes.
Methylation of the majority of T-DMRs negatively corre-
lates with gene expression levels, consistent with the
current notion of an inhibitory role for DNA methyla-
tion; however, the methylation of a significant fraction ofFigure 8 Selected 6-mer motifs from negative, positive or dual T-DMR
transcription factors from databases JASPAR and UniPROBE (middle),
dependent manner (21) (bottom). The red “m” under the CpG representT-DMRs is positively correlated with expression level.
Positive T-DMRs are found more frequent in promoter
regions than negative T-DMRs, as well as in DHS re-
gions. Moreover, the positive T-DMRs are more con-
served than negative T-DMRs. These results together
suggest that the observed positive correlation is not sim-
ply due to chance and these positive T-DMRs are likely
to play a regulatory role.
Although it has been shown by some groups that
DNA methylation in gene bodies correlates with tran-
scriptional activity [7], our observation is novel, and dif-
ferent to the previous findings. First, previous work [7]
showed that non-CpG methylation (i.e. CHG and CHH
methylation) within gene body is positively correlated
with gene expression, while CpG methylation showed no
correlation with gene activity. In our study, we focused
on CpG methylation. Second, the published studies cor-
related DNA methylation and gene expression ranks
among all different genes in one cell condition (e.g. stem
cell line), while our study correlated the methylation dif-
ference and gene expression difference of the same gene
between two tissues [7]. Third, the distributions of posi-
tive and negative DMRs throughout various genomic
features (e.g. promoter, exon and intron) are very similar
(Figure 2a). There is no enrichment for positive DMRs
in gene body. Fourth, it has been found that CpG dens-
ity is one major determinant for functionality of DNA
methylation [5]. Davies et al. also observed that a signifi-
cant overrepresentation of T-DMRs was located in low
CpG density promoters [32]. Interestingly, in our study,s containing CpG sites (top), similar binding sites of matched
and human transcription factors known to bind in a methylation-
s methylated CpG binding site.
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of negative ones (Additional file 2: Figure S2), suggesting
that the positive T-DMRs are a novel discovery.
We find that genes whose expression negatively cor-
related T-DMRs are enriched for functions carried out
in adult tissues, while the positively correlated genes
were enriched for negative regulators such as transcrip-
tional repressors. This possible two-layer regulation
mechanism by positive T-DMRs may be unique to de-
velopment and the establishment of tissue-specific
expression. We do not observe a two-layer regulation
when we analysed the association of cancer-specific
DMRs (C-DMRs) and gene expression differences be-
tween colon cancer and normal tissue (data not shown)
[10]. In the cancer study, genes whose expression is
positively correlated with C-DMRs are not enriched for
transcriptional repressors, suggesting that such a two-
layer regulation mechanism is not an important feature
in the development of cancer.
We find two distinct sets of motifs that associate with
either positive or negative regulation of gene expression.
While only 14% of the predicted motifs associated with
negative gene regulation contain a CpG site, strikingly,
78% of the positive gene regulation motifs contained at
least one CpG, suggesting that distinct sets of TFs partici-
pate in the different potential mechanisms of methylation-
dependent gene regulation. For the positively associated
motifs that contain a CpG site, it may be the methylation
of that specific CpG, which allows the binding of a par-
ticular TF that only binds to methylated DNA and pro-
motes transcription. Conversely, for negative T-DMRs,
generalized methylation of the T-DMR may be more likely
to inhibit transcription by the binding of methyl-binding
proteins rather than a specific TF that only binds to meth-
ylated DNA. Clearly, we still have much to learn about the
varied mechanisms by which DNA methylation can con-
tribute to the regulation of gene expression, particularly in
the establishment of tissue-specific expression during
development.
As discussed previously, early analyses on DNA methy-
lation often focused on promoter regions. However, accu-
mulated evidence suggests that enhancers could activate
gene expression independent of their distance to the pro-
moters of target genes [33-36]. The enhancers could locate
in distal intergenic regions and introns. For this reason, in
our analysis, we did not limit T-DMRs to the promoter re-
gion. Nevertheless, if we performed the similar analysis on
promoter regions, most of the results remain. For ex-
ample, the enrichment scores for motifs from all T-DMRs
and promoter-only analyses are significantly correlated
(Additional file 2: Figure S3). In addition, we also per-
formed the analysis on functional genes. 13 out of 67
(19.4%) genes positively regulated by T-DMRs at pro-
moters of genes encoded negative regulators.As the first step to elucidate the biological role of
DNA methylation, this study examined the correlation
between methylation changes and gene expression
changes. Our study only included a limited number of
tissues from mouse and human, and more extensive ana-
lysis is needed in future to generalize the observation.
Furthermore, functional assays are also needed to sub-
stantiate our bioinformatics findings. For example, to
clarify the association between DNA methylation and TF
binding, TF binding data (e.g. ChIP-seq data) in corre-
sponding cell lines and tissues are necessary to exhibit
the exact TF recruiting by DNA methylation. In our
published work, we demonstrated that some TFs were
preferentially bound to methylated DNA [23]. We ex-
pect that some of the T-DMRs are associated with the
changes of TF recruitment.
Methods
Identification of T-DMRs between mouse retina and brain
Methylation enrichment was performed on adult retina
and brain tissue from C57BL/6 J mice (n = 3) as previ-
ously described [11]. Briefly, methylation-enriched DNA
was compared to input DNA by hybridization to a cus-
tom 2.1 M NimbleGen CHARM array. In total, 2,498 T-
DMRs were identified between retina and brain [21].
Gene expression in mouse retina and brain
We performed analysis of gene expression differences
between adult mouse retina (triplicates) and brain (du-
plicates) [12]. The gene expression data were provided
in Additional file 3: Table S2. When calculating the cor-
relation between gene expression difference (ΔE) and
methylation difference (ΔM), we only considered the
genes with |ΔE| > log2(1.25). If ΔE and ΔM had the same
sign, we consider them having positive correlation and if
different signs, negative correlation.
T-DMRs and genes for human tissues
We preformed the similar T-DMRs analysis on the data
from another independent study [10]. T-DMRs were
identified for p < 0.001. The genes were selected if their
amplitudes of gene expression difference were larger
than log21.5 between brain and liver, or between colon
cancer and normal tissues. We chose the threshold so
that the similar number of differentially expressed genes
were identified for human and mouse.
Tissue-enriched and shared DNase I hypersensitivity sites
(DHSs)
Genomic DHS data for 8-week old mouse retina and brain
were downloaded from the UCSC Genome Browser web-
site: “DNaseI Hypersensitivity by Digital DNaseI from
ENCODE/University of Washington” [17-19]. DHSs were
identified as narrow signal peaks with false discovery rate
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and brain were denoted shared DHSs, whereas those
found only in retina or brain were denoted tissue-specific
DHSs. As there were 7 replicates for mouse brain, only re-
gions verified by 3 out of 7 replicates were defined as brain
DHSs.
Z-scores of number of genes with multiple incoherent/
coherent T-DMRs
In total, 247 genes were identified with multiple T-
DMRs. We kept the same ΔE for each gene and shuffled
the ΔM of T-DMRs across these genes. We then deter-
mined the positive and negative correlation between ΔE
and ΔM for the 247 genes. The number of genes with
coherent and incoherent T-DMRs was counted in the
random simulation. This process was repeated 10,000
times. To evaluate the significance of the observed num-
ber of genes with coherent and incoherent T-DMRs, we




where n is observed number of genes with incoherent/
coherent T-DMRs, S is the set of numbers of genes with
shuffled incoherent/coherent T-DMRs after 10 k times.
S and std(S) are the mean value and standard deviation
of S based on randomly shuffling results.
Gene ontology (GO) analysis
For the tissue-enriched genes associated with T-DMRs de-
fined above, we calculated the enrichment ratio of the oc-
currence of each associated GO term in the group [37],
either positive or negative regulation, to that of the back-
ground genes. The background composed of 10910 genes,
which are expressed in retina and/or brain, and have cor-
responding probes on the CHARM array. The statistical
significance of the p-value was evaluated based on the
hypergeometric distribution model then corrected by
Bonferroni multiple-test correction. Enriched GO terms
were selected with modified p-value less than 0.05.
Motif discovery
To determine the molecular basis of DNA-methylation
dependent gene regulation, we predicted DNA motifs as-
sociated with the T-DMRs. The T-DMRs were divided
into two groups: negative and positive, based on the cor-
relation of DNA methylation with gene expression. For
comparison, we randomly selected 25,000 sequence seg-
ments from the genes with probes in CHARM array,
which is about 10 times of number of T-DMRs. The ran-
dom sequences were selected from upstream 4 kb to the
end of transcription of the genes. Every random se-
quence has the same length of one selected T-DMR.Therefore, the random sequences have the similar length
distribution to that of the T-DMRs identified. We enu-
merated all possible 6-mers and compared their occur-
rence in the T-DMRs to the random sequences. To
evaluate statistical significance of the occurrence of a
given 6-mer, a p-value was calculated by binominal cu-
mulative functions [21]. False discovery rate was calcu-
lated using the Benjamini and Hochberg approach [38].
Only 6-mers with corrected p-values less than 1% (for
all T-DMRs) or 5% (for T-DMRs within DHS) of FDR
were selected as significant motifs. A motif was termed
“dual” if a 6-mer was significantly enriched in both the
negative and positive T-DMRs.
CpG ratio of the T-DMR
CpG ratio of the T-DMR was calculated by frequency of
CpG on the T-DMR divided by multiplication of fre-
quency of C and G [5].
Statistical models for p-value calculation
We used hypergeometric distribution to calculate p-value
unless otherwise noted.
Ethics approval for mice research
All experimental procedures were approved by the Johns
Hopkins University Institutional Animal Care and Use
Committee (IACUC) and were performed in accordance
with guidelines established in the National Research Coun-
cil’s Guide for the Care and Use of Laboratory Animals.
Data deposition
The DNA methylation data can be downloaded at Gene
Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo)
(GSE46683). The gene expression data is included in
Additional file 3: Table S2.
Additional files
Additional file 1: Table S1. Significantly enriched motifs were
identified in all gene-regulating T-DMRs and/or those T-DMRs within
DHS. The p-values were corrected by FDR.
Additional file 2: Figure S1. Correlation of enrichment score of 6-mers’
occurences in all gene-regulating T-DMRs and those within DHS. The top
and bottom plots are for negative regulation and positive regulation,
respectively. Figure S2. Positive T-DMRs have higher CpG ratios than
negative T-DMRs (p = 4.1 × 10−6, two-group t-test). Figure S3. Correlation
of 6-mer occurrence enrichment scores in all gene-regulating.
Additional file 3: Table S2. Gene expression profiles for mouse retina
(triplicates) and brain (duplicates) by Affymetrix exon microarray.
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